Literature DB >> 9354429

Association of human T-cell leukemia virus and myelodysplastic syndrome in a central European population.

H Karlic1, M Möstl, H Mucke, B Pavlova, M Pfeilstöcker, R Heinz.   

Abstract

In addition to a few disorders such as acute T-cell leukemia that are typically associated with the human T-cell leukemia virus (HTLV) 1 in endemic regions, this virus may also play a role in some other hematological diseases. Here, we examine the incidence of HTLV in hematological diseases from a nonendemic region in central Europe. Data obtained by PCR and/or serological techniques from a total of 730 cases showed that besides the expected presence of HTLV-1 in T-lymphoid diseases (2 of 27 cases), HTLV-1 was only detected in myelodysplastic syndrome (MDS), in which an incidence of 17% (11 of 65 cases) was found. A correlation with a history of multiple transfusions or treatment with blood products in the HTLV-1-positive MDS could not be ascertained. Cytogenetics detected the presence of del(5)(q) in six HTLV-positive cases (five MDS and one T-cell acute lymphocytic leukemia) but in only one HTLV-negative case. These data indicate that allelic deletions of a series of 5q-located genes that typically occur in MDS may be associated with HTLV infections in central Europe.

Entities:  

Mesh:

Year:  1997        PMID: 9354429

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  3 in total

1.  Antiretroviral activity of 5-azacytidine during treatment of a HTLV-1 positive myelodysplastic syndrome with autoimmune manifestations.

Authors:  Panagiotis T Diamantopoulos; Maria Michael; Olga Benopoulou; Efthymia Bazanis; George Tzeletas; John Meletis; George Vayopoulos; Nora-Athina Viniou
Journal:  Virol J       Date:  2012-01-03       Impact factor: 4.099

2.  Hematological manifestations of human T lymphotropic virus type 1 infection: a possible association with autoimmune myelofibrosis.

Authors:  Ana Ciminelli; Frederico Melo; Marie-Christine Copin; Anna Bárbara Carneiro-Proietti; Suely Meireles Rezende
Journal:  Rev Bras Hematol Hemoter       Date:  2015-10-09

3.  Myelodysplastic syndrome in a kidney transplant recipient after SARS-CoV-2 infection: can SARS-CoV-2 induce myelodysplastic syndrome?

Authors:  Ivana Juric; Lea Katalinic; Vesna Furic-Cunko; Nikolina Basic-Jukic
Journal:  Int Urol Nephrol       Date:  2021-11-23       Impact factor: 2.370

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.